124 related articles for article (PubMed ID: 36728423)
1. Participation of HIV-1 infected treatment-naive females in clinical trials and sex differences in efficacy and safety outcomes.
Zhou S; Qi K; Nugent BM; Bersoff-Matcha SJ; Struble K
AIDS; 2023 May; 37(6):895-903. PubMed ID: 36728423
[TBL] [Abstract][Full Text] [Related]
2. Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics.
Varma T; Wallach JD; Miller JE; Schnabel D; Skydel JJ; Zhang AD; Dinan MA; Ross JS; Gross CP
JAMA Netw Open; 2021 Apr; 4(4):e217063. PubMed ID: 33877309
[TBL] [Abstract][Full Text] [Related]
3. Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs.
Scott PE; Unger EF; Jenkins MR; Southworth MR; McDowell TY; Geller RJ; Elahi M; Temple RJ; Woodcock J
J Am Coll Cardiol; 2018 May; 71(18):1960-1969. PubMed ID: 29724348
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial.
Currier J; Averitt Bridge D; Hagins D; Zorrilla CD; Feinberg J; Ryan R; Falcon R; Tennenberg A; Mrus J; Squires K;
Ann Intern Med; 2010 Sep; 153(6):349-57. PubMed ID: 20855799
[TBL] [Abstract][Full Text] [Related]
6. Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials.
Reid MM; Davis SP; Henry ON; Mathew AA; McCallister S; Nero TT; Rabheru SA; Sampson SH; Vanderslice TF; Williams DT
Clin Trials; 2023 Apr; 20(2):133-144. PubMed ID: 36744680
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008).
Soon GG; Min M; Struble KA; Chan-Tack KM; Hammerstrom T; Qi K; Zhou S; Bhore R; Murray JS; Birnkrant DB
AIDS Patient Care STDS; 2012 Aug; 26(8):444-53. PubMed ID: 22734949
[TBL] [Abstract][Full Text] [Related]
8. Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015.
Chen A; Wright H; Itana H; Elahi M; Igun A; Soon G; Pariser AR; Fadiran EO
J Womens Health (Larchmt); 2018 Apr; 27(4):418-429. PubMed ID: 29048983
[TBL] [Abstract][Full Text] [Related]
9. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
Adis International Ltd
Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of Older People Reflective of Real-World Clinical Practice in Cardiovascular Drug Trials.
Caughey GE; Inacio MC; Bell JS; Vitry AI; Shakib S
J Am Heart Assoc; 2020 Nov; 9(21):e016936. PubMed ID: 33103558
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.
Perera ND; Bellomo TR; Schmidt WM; Litt HK; Shyu M; Stavins MA; Wang MM; Bell A; Saleki M; Wolf KI; Ionescu R; Tao JJ; Ji S; O'Keefe RM; Pun M; Takasugi JM; Steinberg JR; Go RS; Turner BE; Mahipal A
Oncologist; 2023 Jun; 28(6):510-519. PubMed ID: 36848266
[TBL] [Abstract][Full Text] [Related]
12. Enrollment of female participants in United States drug and device phase 1-3 clinical trials between 2016 and 2019.
Sosinsky AZ; Rich-Edwards JW; Wiley A; Wright K; Spagnolo PA; Joffe H
Contemp Clin Trials; 2022 Apr; 115():106718. PubMed ID: 35247632
[TBL] [Abstract][Full Text] [Related]
13. Participation of women and sex analyses in late-phase clinical trials of new molecular entity drugs and biologics approved by the FDA in 2007-2009.
Poon R; Khanijow K; Umarjee S; Fadiran E; Yu M; Zhang L; Parekh A
J Womens Health (Larchmt); 2013 Jul; 22(7):604-16. PubMed ID: 23768021
[TBL] [Abstract][Full Text] [Related]
14. Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial.
Gallant J; Moyle G; Berenguer J; Shalit P; Cao H; Liu YP; Myers J; Rosenblatt L; Yang L; Szwarcberg J
Curr HIV Res; 2017; 15(3):216-224. PubMed ID: 27774892
[TBL] [Abstract][Full Text] [Related]
15. An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1.
Evitt LA; Nanji S; Grove RA; Okoli C; van Wyk J; Snedecor SJ
AIDS Res Ther; 2023 Mar; 20(1):17. PubMed ID: 36949442
[TBL] [Abstract][Full Text] [Related]
16. HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States.
Landovitz RJ; Tran TT; Cohn SE; Ofotokun I; Godfrey C; Kuritzkes DR; Lennox JL; Currier JS; Ribaudo HJ
AIDS Behav; 2016 Dec; 20(12):2983-2995. PubMed ID: 26979419
[TBL] [Abstract][Full Text] [Related]
17. Participation of women in clinical trials for new drugs approved by the food and drug administration in 2000-2002.
Yang Y; Carlin AS; Faustino PJ; Motta MI; Hamad ML; He R; Watanuki Y; Pinnow EE; Khan MA
J Womens Health (Larchmt); 2009 Mar; 18(3):303-10. PubMed ID: 19243271
[TBL] [Abstract][Full Text] [Related]
18. Tipranavir: PNU 140690, tipranivir.
Drugs R D; 2006; 7(1):55-62. PubMed ID: 16620137
[TBL] [Abstract][Full Text] [Related]
19. Persistent under-representation of female patients in United States trials of common vascular diseases from 2008 to 2020.
Mayor JM; Preventza O; McGinigle K; Mills JL; Montero-Baker M; Gilani R; Pallister Z; Chung J
J Vasc Surg; 2022 Jan; 75(1):30-36. PubMed ID: 34438003
[TBL] [Abstract][Full Text] [Related]
20. Regional variation in HIV clinical trials participation in the United States.
Heumann C; Cohn SE; Krishnan S; Castillo-Mancilla JR; Cespedes M; Floris-Moore M; Smith KY;
South Med J; 2015 Feb; 108(2):107-16. PubMed ID: 25688896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
